Opportunities and challenges in application of artificial intelligence in pharmacology.
Mandeep KumarT P Nhung NguyenJasleen KaurThakur Gurjeet SinghDivya SoniRandhir SinghPuneet KumarPublished in: Pharmacological reports : PR (2023)
Artificial intelligence (AI) is a machine science that can mimic human behaviour like intelligent analysis of data. AI functions with specialized algorithms and integrates with deep and machine learning. Living in the digital world can generate a huge amount of medical data every day. Therefore, we need an automated and reliable evaluation tool that can make decisions more accurately and faster. Machine learning has the potential to learn, understand and analyse the data used in healthcare systems. In the last few years, AI is known to be employed in various fields in pharmaceutical science especially in pharmacological research. It helps in the analysis of preclinical (laboratory animals) and clinical (in human) trial data. AI also plays important role in various processes such as drug discovery/manufacturing, diagnosis of big data for disease identification, personalized treatment, clinical trial research, radiotherapy, surgical robotics, smart electronic health records, and epidemic outbreak prediction. Moreover, AI has been used in the evaluation of biomarkers and diseases. In this review, we explain various models and general processes of machine learning and their role in pharmacological science. Therefore, AI with deep learning and machine learning could be relevant in pharmacological research.
Keyphrases
- artificial intelligence
- big data
- machine learning
- deep learning
- electronic health record
- healthcare
- clinical trial
- public health
- endothelial cells
- drug discovery
- convolutional neural network
- study protocol
- early stage
- radiation therapy
- phase iii
- palliative care
- clinical decision support
- pluripotent stem cells
- stem cells
- cell therapy
- open label
- placebo controlled
- rectal cancer